Industry-first bio-based PVC for medical launched
TekniPlex Healthcare has claimed to become the first healthcare solutions company to introduce bio-based polyvinyl chloride (PVC) for medical applications, with performance and compositional properties equivalent to conventional polyvinyl chloride (PVC) resins.
TekniPlex Healthcare introduces bio-based PVC for medical applications.
The bio-based, medical-grade PVC compounds are equivalent to traditional medical-grade PVC in terms of chemical composition, functionality, and regulatory viability.
The compounds are drop-in replacement for a wide variety of injection molded or extruded PVC compounds. They can be applied in tubing solutions such as IV therapy tube sets, drip chambers, and peristaltic pump tubing, films used for trays, pouches, bags and other form-fill-seal settings, as well as other components composed of medical-grade plastics.
Certified through the globally recognized ISCC PLUS system, the bio-based PVC compounds utilize resins and plasticizers manufactured with renewable energy and bio-attributed classification.
The compounds can reduce carbon emissions by up to 90% compared with conventional PVC resins, and approximately 60% relative to traditional PVC plasticizers.
The bio-based, medical-grade PVC compounds are produced at TekniPlex Healthcare’s manufacturing facility in Belfast, Northern Ireland.
